10.13.20

Will Kids Get A COVID-19 Vaccine? Pfizer To Expand Trial To Ages 12 And Up

Source: NPR

Pfizer announced Monday that it has received FDA approval to enroll children as young as 12 years old in its COVID-19 vaccine trial. The expansion is aimed at understanding whether the vaccine would be safe and effective for adolescents, according to an NPR report.

Until now, children under 16 have not been included in any of the COVID-19 vaccine trials in the U.S., and the average age of participants has skewed much older.

Read the full article.

Related Content